<SEC-DOCUMENT>0001193125-18-233206.txt : 20180731
<SEC-HEADER>0001193125-18-233206.hdr.sgml : 20180731
<ACCEPTANCE-DATETIME>20180731161915
ACCESSION NUMBER:		0001193125-18-233206
CONFORMED SUBMISSION TYPE:	424B7
PUBLIC DOCUMENT COUNT:		2
FILED AS OF DATE:		20180731
DATE AS OF CHANGE:		20180731

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Premier, Inc.
		CENTRAL INDEX KEY:			0001577916
		STANDARD INDUSTRIAL CLASSIFICATION:	SERVICES-MANAGEMENT SERVICES [8741]
		IRS NUMBER:				000000000

	FILING VALUES:
		FORM TYPE:		424B7
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-199158
		FILM NUMBER:		18981348

	BUSINESS ADDRESS:	
		STREET 1:		13034 BALLANTYNE CORPORATE PLACE
		CITY:			CHARLOTTE
		STATE:			NC
		ZIP:			28277
		BUSINESS PHONE:		704-357-0022

	MAIL ADDRESS:	
		STREET 1:		13034 BALLANTYNE CORPORATE PLACE
		CITY:			CHARLOTTE
		STATE:			NC
		ZIP:			28277
</SEC-HEADER>
<DOCUMENT>
<TYPE>424B7
<SEQUENCE>1
<FILENAME>d583066d424b7.htm
<DESCRIPTION>424B7
<TEXT>
<HTML><HEAD>
<TITLE>424B7</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">


<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="50%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Prospectus Supplement No. 15</B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>(To
Prospectus dated November&nbsp;12, 2014, as</B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>supplemented by prospectus supplements</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman"><B>identified on Appendix I hereto)</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Filed pursuant to Rule 424(b)(7)</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Registration <FONT STYLE="white-space:nowrap">No.&nbsp;333-199158</FONT></B></P></TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>111,866,539 Shares </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g583066image0001.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:14pt; font-family:Times New Roman" ALIGN="center"><B>Premier, Inc. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:14pt; font-family:Times New Roman" ALIGN="center"><B>Class&nbsp;A common stock </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This prospectus supplement no. 15 supplements and amends the prospectus dated November&nbsp;12, 2014, as previously supplemented by the
prospectus supplements identified on Appendix I hereto (together, the Prospectus), covering the resale from time to time by selling stockholders named in the Prospectus of up to an aggregate of 111,866,539 shares of our Class&nbsp;A common stock
that may be issued in exchange for Class&nbsp;B common units of limited partnership, or Class&nbsp;B common units, in Premier Healthcare Alliance, L.P. (Premier LP) and an equal number of shares of our Class&nbsp;B common stock, pursuant to certain
contractual rights of the limited partners of Premier LP. Our wholly-owned subsidiary, Premier Services, LLC, is the general partner of Premier LP. This prospectus supplement is not complete without, and may not be utilized except in connection
with, the Prospectus, including any amendments or supplements thereto. This prospectus supplement is qualified by reference to the Prospectus, except to the extent that the information provided by this prospectus supplement supersedes information
contained in the Prospectus. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our Class&nbsp;A common stock is traded on the NASDAQ Global Select Market, or NASDAQ, under the symbol
&#147;PINC.&#148; On July&nbsp;30, 2018, the last reported sales price of our common stock on NASDAQ was $37.04 per share. </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Investing in
our securities involves risks. You should read carefully and consider the &#147;Risk Factors&#148; included in our most recent Annual Report on Form <FONT STYLE="white-space:nowrap">10-K,</FONT> as may be updated by our periodic and current reports,
all of which is incorporated by reference herein, before investing in our Class&nbsp;A common stock. </B></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Neither the
Securities and Exchange Commission nor any state securities commission has approved or disapproved of these securities or determined if this prospectus supplement is truthful or complete. Any representation to the contrary is a criminal
offense.</B></P> <P STYLE="font-size:48pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="font-size:48pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="font-size:48pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:48pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">The date of this prospectus supplement is July&nbsp;31, 2018. </P>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>SELLING STOCKHOLDERS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The information in the table appearing under the heading &#147;Selling Stockholders&#148; in the Prospectus is supplemented and amended by the
following information, which includes information with respect to selling stockholders not previously listed in the Prospectus and supersedes information with respect to the selling stockholders listed below as of the date of this prospectus
supplement. The following updated information supplements the information in such table, is based solely upon information provided to us by the&nbsp;selling stockholders&nbsp;and is accurate, to the best of our knowledge, as of July&nbsp;31, 2018.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Pursuant to the terms of the LP Agreement and the Exchange Agreement, each Class&nbsp;B common unit of Premier LP held by the selling
stockholders is exchangeable for one share of our Class&nbsp;A common stock, cash or a combination of both, subject to certain exchange timing and volume limitations. See &#147;Certain Contractual Arrangements with Selling Stockholders&#148; in the
Prospectus for additional information. The following table sets forth the selling stockholders&#146; beneficial ownership of our Class&nbsp;A common stock as of the date of this prospectus supplement. Each selling stockholder has the cumulative
right to exchange a maximum of <FONT STYLE="white-space:nowrap">one-seventh</FONT> of its initial allocation of Class&nbsp;B common units (as well as any additional Class&nbsp;B common units purchased by such selling stockholder pursuant to the
right of first refusal under the Exchange Agreement) each year, commencing on October&nbsp;31, 2014. The number and percentage of shares beneficially owned after this offering for each selling stockholder assumes the exchange by the selling
stockholders of all Class&nbsp;B common units owned by them for the equivalent number of our shares of Class&nbsp;A common stock and sale of all such shares offered by the selling stockholders and that each selling stockholder does not acquire any
additional shares or units. Information in the table below with respect to beneficial ownership has been furnished by each of the selling stockholders. Beneficial ownership is determined in accordance with the rules and regulations of the Securities
and Exchange Commission. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The selling stockholders are not required to exchange their Class&nbsp;B common units for shares of our
Class&nbsp;A common stock, nor are we required to issue shares of Class&nbsp;A common stock to any selling stockholder who elects to exchange Class&nbsp;B common units. Instead, we may satisfy the Class&nbsp;B common unit exchanges by paying cash or
through a combination of cash and Class&nbsp;A common stock. In addition, the selling stockholders listed in the table below may have sold, transferred, otherwise disposed of or purchased, or may sell, transfer, otherwise dispose of or purchase, at
any time and from time to time, Class&nbsp;B common units or shares of our Class&nbsp;A common stock in transactions exempt from the registration requirements of the Securities Act or in the open market after the date on which they provided the
information set forth in the table below. The maximum number of shares of Class&nbsp;A common stock offered hereby assumes the selling stockholders exchange all of their Class&nbsp;B common units held on the date on which they provided the
information set forth in the table below and we elect to satisfy all exchange requests by issuing only shares of Class&nbsp;A common stock. Assuming we do issue shares of our Class&nbsp;A common stock to a holder of Class&nbsp;B common units upon an
exchange, such holder may offer for sale all, some or none of such shares of Class&nbsp;A common stock. Therefore, it is difficult to estimate with any degree of certainty the aggregate number of shares that the selling stockholders will ultimately
offer pursuant to this prospectus supplement or that the selling stockholders will ultimately own upon completion of the offering to which this prospectus supplement relates. The following table does not take into effect any restrictions on
ownership or transfer as described in &#147;Description of Capital Stock&#148; in the Prospectus. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-1 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The selling stockholders named below and their permitted transferees, pledgees, orderees or other
successors may from time to time offer the shares of our Class&nbsp;A common stock offered by this prospectus supplement. Except as otherwise indicated in the footnote below, the beneficial owner has sole voting and investment power with respect to
the indicated shares of Class&nbsp;A common stock. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" ALIGN="center">


<TR>
<TD WIDTH="52%"></TD>
<TD VALIGN="bottom" WIDTH="9%"></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="9%"></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="9%"></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="9%"></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; width:97.00pt; display:inline; font-size:8pt; font-family:Times New Roman; "><B>Name of Selling Stockholder</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Total Number of</B><br><B>Shares&nbsp;of&nbsp;Class&nbsp;A&nbsp;Common</B><br><B>Stock Beneficially Owned</B><br><B>Prior to this Offering<SUP
STYLE="font-size:85%; vertical-align:top">(1)</SUP></B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Maximum&nbsp;Number&nbsp;of</B><br><B>Shares&nbsp;of</B><br><B>Class&nbsp;A&nbsp;Common</B><br><B>Stock&nbsp;Being&nbsp;Offered</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="3" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Total Number of</B><br><B>Shares&nbsp;of&nbsp;Class&nbsp;A&nbsp;Common</B><br><B>Stock Beneficially Owned</B><br><B>After this Offering</B></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Number</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>&nbsp;&nbsp;&nbsp;&nbsp;%&nbsp;&nbsp;&nbsp;&nbsp;</B></TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Pandion Sourcing National LLC(2)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">0</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">513,406</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">0</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">*</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Summa Health</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">490,036</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">857,566</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">0</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">*</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Henry Ford Health System(3)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">0</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">862,954</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">0</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">*</TD></TR>
</TABLE> <P STYLE="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:10%">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">*</TD>
<TD ALIGN="left" VALIGN="top">Represents less than 1.0%. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top">If applicable, beneficial ownership prior to this offering is reflected as 0 for selling stockholders who have provided us information regarding their Class&nbsp;A common stock ownership but do not otherwise own any
shares of Class&nbsp;A common stock and have not elected to exchange their portion of Class&nbsp;B common units of Premier LP eligible for exchange on the July&nbsp;31, 2018 quarterly exchange date under the Exchange Agreement. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top">Formerly known as Seagate Alliance LLC, and initially identified in our registration statement on Form <FONT STYLE="white-space:nowrap">S-3</FONT> filed with the Securities and Exchange Commission on November&nbsp;12,
2014. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(3)</TD>
<TD ALIGN="left" VALIGN="top">Includes shares that were transferred to Henry Ford Health System (&#147;HFHS&#148;) from W.A. Foote Memorial Hospital d/b/a Allegiance Health (&#147;W.A. Foote Memorial&#148;) on July&nbsp;1, 2018. HFHS was initially
identified in our registration statement on Form <FONT STYLE="white-space:nowrap">S-3</FONT> filed with the Securities and Exchange Commission on November&nbsp;12, 2014. W.A. Foote Memorial was initially identified in prospectus supplement number 2,
dated February&nbsp;2, 2015. </TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-2 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B><U>Appendix I </U></B></P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Table of Prospectus Supplements </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>To </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Prospectus dated
November&nbsp;12, 2014 </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="51%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="47%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom" ALIGN="center"><B>Prospectus Supplement Number</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center"><B>Date of Prospectus Supplement</B></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom" ALIGN="center">Number 1</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">November&nbsp;13, 2014</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom" ALIGN="center">Number 2</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">February&nbsp;2, 2015</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom" ALIGN="center">Number 3</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">April&nbsp;30, 2015</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom" ALIGN="center">Number 4</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">July&nbsp;31, 2015</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom" ALIGN="center">Number 5</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">November&nbsp;2, 2015</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom" ALIGN="center">Number 6</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">November&nbsp;10, 2015</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom" ALIGN="center">Number 7</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">February&nbsp;1, 2016</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom" ALIGN="center">Number 8</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">May&nbsp;2, 2016</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom" ALIGN="center">Number 9</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">August&nbsp;1, 2016</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom" ALIGN="center">Number 10</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">January&nbsp;31, 2017</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom" ALIGN="center">Number 11</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">July&nbsp;31, 2017</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom" ALIGN="center">Number 12</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">October&nbsp;31, 2017</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom" ALIGN="center">Number 13</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">January&nbsp;31, 2018</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom" ALIGN="center">Number 14</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">April&nbsp;30, 2018</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-3 </P>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>g583066image0001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g583066image0001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_X@Q824-#7U!23T9)3$4  0$   Q(3&EN
M;P(0  !M;G1R4D="(%A96B 'S@ "  D !@ Q  !A8W-P35-&5     !)14,@
M<U)'0@                  ]M8  0    #3+4A0("
M                                             !%C<')T   !4
M #-D97-C   !A    &QW='!T   !\    !1B:W!T   "!    !1R6%E:   "
M&    !1G6%E:   "+    !1B6%E:   "0    !1D;6YD   "5    '!D;61D
M   "Q    (AV=65D   #3    (9V:65W   #U    "1L=6UI   #^    !1M
M96%S   $#    "1T96-H   $,     QR5%)#   $/   " QG5%)#   $/
M" QB5%)#   $/   " QT97AT     $-O<'ER:6=H=" H8RD@,3DY."!(97=L
M971T+5!A8VMA<F0@0V]M<&%N>0  9&5S8P         2<U)'0B!)14,V,3DV
M-BTR+C$              !)S4D="($E%0S8Q.38V+3(N,0
M                                                    6%E:(
M     /-1  $    !%LQ865H@                     %A96B        !O
MH@  ./4   .06%E:(        &*9  "WA0  &-I865H@        )*    ^$
M  "VSV1E<V,         %DE%0R!H='1P.B\O=W=W+FEE8RYC:
M    %DE%0R!H='1P.B\O=W=W+FEE8RYC:
M                                  !D97-C         "Y)14,@-C$Y
M-C8M,BXQ($1E9F%U;'0@4D="(&-O;&]U<B!S<&%C92 M('-21T(
M     "Y)14,@-C$Y-C8M,BXQ($1E9F%U;'0@4D="(&-O;&]U<B!S<&%C92 M
M('-21T(                             9&5S8P         L4F5F97)E
M;F-E(%9I97=I;F<@0V]N9&ET:6]N(&EN($E%0S8Q.38V+3(N,0
M    +%)E9F5R96YC92!6:65W:6YG($-O;F1I=&EO;B!I;B!)14,V,3DV-BTR
M+C$                                  '9I97<      !.D_@ 47RX
M$,\4  /MS  $$PL  UR>     5A96B       $P)5@!0    5Q_G;65A<P
M       !                         H\    "<VEG(     !#4E0@8W5R
M=@        0     !0 *  \ %  9 !X (P H "T ,@ W #L 0 !% $H 3P!4
M %D 7@!C &@ ;0!R '< ? "! (8 BP"0 )4 F@"? *0 J0"N +( MP"\ ,$
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M])5?E<F6-):?EPJ7=9?@F$R8N)DDF9"9_)IHFM6;0INOG!R<B9SWG62=TIY
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M)R<L+"S_P  1" !% 2<# "(  1$! A$"_\0 'P   04! 0$! 0$
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L !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!__]D!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
